Applicability of Techniques of Lung Expansion

November 22, 2015 updated by: Caio César Araújo Morais, Universidade Federal de Pernambuco

Immediate Effect of Expiratory Positive Airway Pressure and Breath Stacking in Non-cooperative Patients Detected by Electrical Impedance Tomography

The survival of patients with lesions in the central nervous system is usually accompanied by physical and mental sequelae. These impairments favor the prolonged restriction to the bed, which may contribute with changes in respiratory function. In this context, lung re-expansion techniques are used to prevent or treat the various respiratory complications.

Study Overview

Status

Completed

Conditions

Detailed Description

The survival of patients with lesions in the Central Nervous System is usually accompanied by physical and mental permanents sequelae. This impairment of cognitive status associated with motor injury favors prolonged restriction of these patients to the bed, which may contribute to the emergence of other health damages. In the clinical practice, lung expansion techniques has been used as a prophylaxis and treatment of respiratory conditions that involve volumetric reductions. However, the deficit of awareness and cooperation difficult the use of several therapeutic resources. There are few interventions that could be proposed due to no need the collaboration to be performed, such as Breath Stacking technique (BS) and Expiratory Positive Airway Pressure (EPAP). The BS is characterized by execution of inspiratory cycles through a one way valve, which allows stacked volume of gas during each inspiration, until it reaches values approximate to maximum inspiratory capacity. While in the EPAP, alveolar pressure is elevated to breath against a expiratory flow resistance generated by a spring load valve. The effects on lung volume promoted BS and EPAP can be safely measured using an electrical impedance tomography (EIT). This recent imaging modality offers information about lung air volumes distribution and have a strong linear correlation with regional ventilation within the thorax. The effects on lung volume promoted BS and EPAP can be safely measured using an EIT monitor. This recent imaging modality offers information about lung air volumes distribution and have a strong linear correlation with regional ventilation within the thorax. Until this moment, there is not description about the effect of lung expansion techniques on regional lung parameters.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • PE - Pernambuco
      • Recife, PE - Pernambuco, Brazil, 50670330
        • Hospital of Clinics of the Federal University of Pernambuco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. Patients undergoing neurosurgery restricted to bed for more than 14 days;
  2. Aged between 18 and 65 years;
  3. Glasgow Coma Scale < 10 points;
  4. Breathing spontaneously through the tracheostomy tube;
  5. No respiratory infection;
  6. Chest circumference between 88 and 98 centimeters;

Exclusion criteria:

  1. Presence of chronic lung diseases;
  2. Chest deformity;
  3. Rib fracture;
  4. Asymmetrical chest expansion;
  5. Abdomen distension;
  6. Spasticity in any hemisphere with Ashworth Scale score more than 2 points for upper limbs;
  7. Uncoordinated movements of the limbs;
  8. Cardiorespiratory instability (heart rate < 60 or > 120 bpm; respiratory rate > 35 ipm; mean arterial pressure < 60 mmHg or > 120 mmHg; oxygen saturation < 90%).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EPAP Group
The EPAP devices increase the alveolar pressure. This effect is obtained through valves that generate a resistance to airflow during expiration.
The EPAP will be applied with a Spring Load Valve Resistor (Vital Signs, Totowa, NJ, USA), adjusted with a pressure of 10 cmH2O. The Spring Load Valve Resistor will be connected to the expiratory branch of the T-tube. Duration of intervention: 5 minutes.
Other Names:
  • Expiratory Positive Airway Pressure
Experimental: Breath Stacking Group
The Breath Stacking consists on the implementation of subsequent inspiratory efforts through a one way valve, which allows stacked volume of gas during each inspiration, until it reaches a maximum lung volume.
The BS will be performed by a T-tube with a one-way inspiratory valve and the expiratory branch occluded. The expiratory occlusion is maintain until observed the presence of a plateau in the impedance plethysmogram by EIT, which corresponds to the absence of inspired air displacement or when a maximum time of 40 seconds was attained. Durantion of intervention:Three BS interventions will be performed at one minute intervals between them.
Other Names:
  • Air Stacking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Regional Lung Aeration
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Regional Lung Aeration (difference between the End-Expiratory Lung Impedance before and post-intervention). Each image along the time represent the relative change in impedance distribution within the transverse section of the chest, from the first scan (before intervention) to current scan. The pixel values are express as percentage changes of local impedance.
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Regional Lung Ventilation
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Regional Lung Ventilation (difference between end-inspiratory and end-expiratory lung impedance before and post-intervention).
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Heart Rate
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Heart Rate (beats per minute).
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Mean Arterial Pressure
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Mean Arterial Pressure (mmHg)
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Respiratory Rate
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Respiratory Rate (breath per minute)
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Periferic Saturation of Oxygen
Time Frame: Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.
Change in Periferic Saturation of Oxygen (fraction of oxygen-saturated hemoglobin relative to total hemoglobin).
Before and 1, 5, 10, 15, 30, 60, 90, 120 minutes post-intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Caio César A Morais, Master, Universidade Federal de Pernambuco
  • Study Chair: Shirley L Campos, PHD, Universidade Federal de Pernambuco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

October 25, 2013

First Submitted That Met QC Criteria

November 22, 2015

First Posted (Estimate)

November 25, 2015

Study Record Updates

Last Update Posted (Estimate)

November 25, 2015

Last Update Submitted That Met QC Criteria

November 22, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Caio01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on EPAP

Subscribe